Lipoedema

Lipoedema: recognising and managing a commonly misdiagnosed condition

Lipoedema is a chronic progressive disorder of subcutaneous adipose tissue causing symmetric, painful, diet-resistant fat accumulation in the lower limbs, almost exclusively in women. The feet are spared (ankle cuff sign) and Stemmer's sign is negative, distinguishing it from lymphoedema. Management is multimodal: flat-knit class II compression, manual lymphatic drainage, water-based exercise, anti-inflammatory diet, and psychological support. Tumescent liposuction is the definitive intervention but is not Medicare-rebatable in Australia. Naming the diagnosis is itself therapeutic — it reframes years of misdiagnosis as obesity.

Lipoedema is a chronic, progressive disorder of subcutaneous adipose tissue that affects almost exclusively women, with an estimated Australian prevalence of approximately 11% of women. Despite this prevalence, it is routinely misdiagnosed as obesity — sometimes for decades — causing significant harm through dietary cycling, self-blame, weight stigma, and delayed access to appropriate care. Recognising lipoedema in general practice and naming it correctly are the most important clinical interventions available.

The condition involves symmetrical accumulation of disproportionate, painful, diet-resistant fat in the lower limbs (and sometimes upper limbs), triggered by hormonal events — most commonly puberty, pregnancy, and menopause — and associated with microvascular fragility, chronic low-grade inflammation, and ultimately secondary lymphatic compromise in advanced disease.

A. Core clinical — the AU general-practice framework

History

The Australasian Lymphology Association (ALA) and Standards of Care for Lipedema 2024 provide the diagnostic framework used in Australian practice.

Diagnostic criteria (Foeldi / Standards of Care): Diagnosis is clinical. All of the following should be present:

  • Bilateral, symmetric fat distribution in the lower limbs (thighs, lower legs; sometimes upper limbs)
  • Sparing of the feet — the characteristic ankle cuff at the malleoli where lipoedematous tissue transitions abruptly to normal feet
  • Pain or tenderness on palpation of affected tissue
  • Easy bruising without proportionate trauma — due to capillary fragility
  • Resistance of affected fat to caloric restriction and exercise
  • History consistent with a hormonal trigger (puberty, pregnancy, menopause, exogenous oestrogen)
  • Family history often positive (~60% of affected patients report an affected female relative)
  • Stemmer’s sign negative (skin can be lifted over dorsum of second toe or finger — feet are unaffected)

Hormonal triggers to ask about: Combined oral contraceptive commencement, pregnancy, menopause, or exogenous oestrogen all can trigger or accelerate lipoedema, likely through effects on adipogenesis and vascular permeability.

Psychosocial history: Ask explicitly about years of failed dieting, misdiagnosis history, weight stigma experiences, depression, anxiety, eating disorder history, and suicidality. The psychological burden of chronic misdiagnosis is a medical issue in its own right.

Examination

  • Distribution: symmetric lower limb fat with clear ankle cuff; measure limb circumference at standardised points
  • Stemmer’s sign: attempt to lift skin fold over dorsum of second toe — negative in lipoedema (positive in lymphoedema)
  • Palpation: tenderness over affected adipose is characteristic; observe for bruising
  • Skin texture: soft, nodular (Stage 1), dimpled (Stage 2), or pendulous lobular with hard fibrotic feel (Stage 3)
  • Gait: assess for functional impairment from disproportionate lower-limb weight

ISL Staging: Per International Society of Lymphology 2020 and Wounds Australia — Stage 1 (smooth skin, nodular subcutaneous tissue), Stage 2 (dimpled/mattress skin), Stage 3 (large lobules, gait disturbance), Stage 4 (lipo-lymphoedema: foot involvement, positive Stemmer’s, recurrent cellulitis risk).

Investigations

Imaging is rarely needed for routine diagnosis. Workup addresses comorbidities and establishes metabolic baseline:

  • FBC, UEC, LFT, fasting lipids, HbA1c, TSH, ferritin, vitamin D, fasting insulin (insulin resistance and PCOS are common comorbidities)
  • Consider sleep study referral if symptoms of obstructive sleep apnoea
  • ECG if pre-operative or cardiac risk

B. Evidence base — distinguishing lipoedema from its look-alikes

The key diagnostic challenge in general practice is separating lipoedema from obesity, lymphoedema, chronic venous insufficiency, and the combined lipo-lymphoedema of Stage 4.

FeatureLipoedemaSimple obesityLymphoedemaChronic venous insufficiency
DistributionSymmetric lower limbs >> trunkGeneralised; trunk affectedUsually asymmetricAsymmetric or bilateral lower leg (gaiter)
Foot involvementSpared (ankle cuff sign)ProportionateInvolved (dorsal foot)Variable
Pain/tendernessMarked tenderness, easy bruisingUsually absentHeaviness more than painAching, end-of-day heaviness
Stemmer’s signNegativeNegativePositiveNegative
Response to dietingResistant in affected areasRespondsNot applicableHelps

The diagnostic errors most commonly made in general practice are:

  1. Attributing all fat to caloric excess — lipoedematous fat is genuinely resistant to dietary restriction; patients who have repeatedly tried and failed to reduce their lower limb volume are not non-compliant
  2. Calling every bilateral leg swelling lymphoedema — the ankle cuff and negative Stemmer’s sign distinguishes lipoedema from primary or secondary lymphoedema
  3. Missing Stage 4 lipo-lymphoedema — when foot involvement begins and Stemmer’s sign becomes positive, the secondary lymphatic component requires management as lymphoedema as well as lipoedema

Buck et al (Plast Reconstr Surg 2016) validated the clinical diagnostic criteria and found high inter-rater reliability among trained examiners — these criteria work in general practice.

C. Conservative and surgical management

Management is multimodal and lifelong (ALA; Wounds Australia; Standards of Care 2024).

1. Validate the diagnosis. Naming lipoedema is therapeutic — it reframes a disease patients have been told is self-inflicted obesity, mitigates self-blame, and opens access to evidence-based care. Document it clearly in the clinical record. Refer to Lipoedema Australia for peer support and education.

2. Graduated flat-knit compression (foundation, lifelong). Flat-knit compression class II (20–30 mmHg) minimum; class III for advanced disease or post-procedure. Worn on rising, removed at bedtime. Custom-fit for irregular lower-limb proportions; replaced six-monthly. Not PBS-funded — cost approximately $150–$400 per garment. NDIS may fund for Stage 3 or higher with documented functional impairment.

3. Manual lymphatic drainage (MLD) and complex decongestive therapy. Performed by an ALA-certified lymphoedema practitioner — reduces pain, fibrosis, and swelling. Particularly valuable in Stage 2–4 and perioperatively around liposuction. Access via the GP Chronic Care Management Plan (GPCCMP items 965/967).

4. Exercise — water-based first. Aquaaerobics, hydrotherapy, and swimming provide hydrostatic compression alongside low-impact cardiovascular and lymphatic benefit. An exercise physiologist via GPCCMP can develop an individualised program. Avoid high-impact exercise that loads disproportionately heavy lower limbs in advanced disease.

5. Anti-inflammatory dietary pattern. Mediterranean or anti-inflammatory eating patterns are recommended by Standards of Care 2024 given the inflammatory pathophysiology. Avoid crash dieting — trunk fat reduces (worsening disproportion) while lipoedematous fat persists, and dietary restriction cycles contribute to binge eating and worsening body image. A dietitian via GPCCMP provides individualised, sustainable planning.

6. Mental health support. Mental Health Care Plan (items 2715/2717) for a psychologist with experience in body image, chronic illness, weight stigma, and eating disorders. Screen for depression and suicidality at every significant consultation given the burden of chronic misdiagnosis.

7. Liposuction — the definitive intervention. Tumescent liposuction or water-jet assisted liposuction by a lipoedema-trained plastic surgeon reduces pain, mobility limitations, and quality of life burden in observational studies (Wright Plast Reconstr Surg 2016; Schmeller Plast Reconstr Surg 2012). It is staged across multiple operations. Not Medicare-rebatable in Australia (categorised as cosmetic) — approximately $15,000–$30,000 out-of-pocket per limb. Refer to a plastic surgeon trained specifically in lipoedema technique, not general cosmetic liposuction (which can damage the lymphatics). Pre-operative MLD and post-operative compression with MLD are essential.

D. Australian operations

PBS-listed medications relevant to lipoedema management:

  • Paracetamol and NSAIDs — OTC or general schedule; first-line for pain
  • Gabapentin/pregabalin — PBS Authority Required for neuropathic pain; pregabalin is SafeScript-monitored in participating states — check RTPM at prescribing
  • Metformin — PBS Authority Required for type 2 diabetes; off-label for metabolic/PCOS overlap (private script if no diabetes)
  • GLP-1 receptor agonists (semaglutide/tirzepatide) — PBS Authority Required for type 2 diabetes only; private prescription for obesity (~$300–$550 per month); addresses overlying obesity, not lipoedematous fat — counsel expectations clearly

MBS items:

  • Consultation: items 23, 36, 44; telehealth items 91790/92029/92060 for review of established patients
  • GPCCMP preparation item 965, review item 967 — lipoedema qualifies as a chronic condition; allied health (lymphoedema practitioner, exercise physiologist, dietitian, psychologist)
  • Mental Health Care Plan: items 2715/2717
  • Specialist referral: items 105/106 for plastic surgery, vascular, endocrinology, or gynaecology
  • Aboriginal and Torres Strait Islander health assessment: item 715

NDIS: Stage 3 or higher lipoedema with documented functional impairment may qualify — occupational therapy functional assessment and medical evidence are needed; garments, MLD therapy, and assistive technology may be funded.

Lipoedema Australia: National patient advocacy and peer-support organisation — lipoedemaaustralia.com.au. Referral to this resource is recommended at diagnosis.

E. Special populations

Young women with early onset (puberty). Lipoedema often begins at puberty. Distinguish from physiological pubertal changes in fat distribution — lipoedema involves tenderness and disproportionate lower-limb accumulation relative to trunk. Early compression and psychological support reduce long-term progression of stigma and avoidance.

Pregnancy. Pregnancy is a recognised hormonal trigger for lipoedema progression; monitor closely. Metformin for PCOS and GLP-1 agonists for obesity are generally contraindicated in pregnancy — review medications pre-conception. Graduated compression is safe and recommended.

Menopause. Menopausal hormonal transition is another inflection point; lipoedema may progress. Menopausal hormone therapy decisions require careful assessment of the oestrogenic load — an endocrinologist or menopause-experienced GP should co-manage.

Patients with PCOS or insulin resistance. PCOS is a common comorbidity — screen with fasting insulin, SHBG, and androgenic hormones. Insulin sensitisation (metformin, lifestyle) addresses the metabolic component but does not reduce lipoedematous fat volume.

Aboriginal and Torres Strait Islander patients. Higher baseline metabolic risk and barriers to accessing specialist services including lymphoedema practitioners in remote settings. GPCCMP and item 715 health assessment are the primary access vehicles. Coordinate with Aboriginal Community Controlled Health Organisations.

When to escalate

Refer to:

  • ALA-certified lymphoedema practitioner — at diagnosis; lifelong management relationship
  • Plastic surgeon (lipoedema-trained) — when conservative management is optimised and liposuction candidacy is to be discussed; not to a general cosmetic surgeon
  • Vascular surgery — if concurrent chronic venous insufficiency or phlebolymphoedema
  • Endocrinology/gynaecology — comorbid PCOS, oestrogen-driven progression, menopause
  • Clinical psychologist (MHCP) — body image, chronic pain, weight stigma, eating disorder risk
  • Sleep medicine — obstructive sleep apnoea is a frequent comorbidity

Escalate urgently for:

  • Acute skin changes with warmth, erythema, systemic fever — cellulitis; antibiotic treatment per lymphoedema pathway
  • Suicidality — emergency mental health pathway; immediate safety planning

What this article is and is not

This is general health information compiled from current Australian lymphology, wound care, and general practice guidelines — Australasian Lymphology Association, Wounds Australia, RACGP, eTG, and international Standards of Care 2024 — and peer-reviewed surgical evidence. It is not personal medical advice and does not create a doctor–patient relationship. Decisions about compression, liposuction, and medications are made with the treating general practitioner and relevant specialists.

For Australian consumer resources: Lipoedema Australia, Australasian Lymphology Association, HealthDirect, Better Health Channel.


Sources cited

  1. Australasian Lymphology Association (ALA) — Lipoedema position
  2. Wounds Australia — Lipoedema clinical resource
  3. Lipoedema Australia
  4. RACGP — Lipoedema recognition (AJGP)
  5. Therapeutic Guidelines (eTG)
  6. Australian Medicines Handbook
  7. Standards of Care for Lipedema — US 2024
  8. International Society of Lymphology — Consensus Document 2020
  9. Wright et al — Lipoedema liposuction outcomes (Plast Reconstr Surg 2016)
  10. Schmeller et al — Tumescent liposuction in lipoedema (Plast Reconstr Surg 2012)
  11. Buck et al — Lipoedema review and diagnostic criteria (Plast Reconstr Surg 2016)
  12. HealthDirect — Lipoedema
  13. Better Health Channel — Lipoedema

Frequently asked questions

  • How is lipoedema different from obesity?

    Both conditions can coexist, but they are distinct. In lipoedema, fat accumulates symmetrically in the lower limbs and is painful and tender on palpation, easy bruising is characteristic, the feet are spared, and the fat does not reduce with caloric restriction or exercise. In simple obesity, fat distributes more uniformly (including the trunk), tenderness and easy bruising are absent, and dieting reduces fat in the affected areas. Misdiagnosis of lipoedema as obesity is common and harmful — it leads to years of failed dieting, self-blame, and delayed access to appropriate care.

  • What is Stemmer's sign and why does it matter?

    Stemmer's sign is a bedside test performed by attempting to pinch and lift a fold of skin over the dorsum of the second toe or finger. A positive result (skin cannot be lifted into a fold) indicates skin thickening from lymphoedema affecting the digits and feet. In lipoedema, Stemmer's sign is negative because the feet are spared — the characteristic ankle cuff of lipoedematous fat stops at the ankle, leaving the foot unaffected. This makes Stemmer's sign the key bedside discriminator between lipoedema and lymphoedema, which is important because they require different management.

  • Why is liposuction the only thing that removes lipoedematous fat, and is it covered by Medicare?

    Lipoedematous fat has abnormal adipocyte and microvascular structure that does not respond to caloric deficit the way ordinary fat does. Tumescent or water-jet assisted liposuction by a lipoedema-trained plastic surgeon reduces pain, improves mobility, and has durable quality-of-life benefits in observational studies. However, it is not Medicare-rebatable in Australia — the procedure is categorised as cosmetic — leaving patients with out-of-pocket costs of approximately $15,000–$30,000 per limb per staged operation. Advocacy for MBS listing is ongoing via Lipoedema Australia and the Australasian Lymphology Association.

  • What type of compression garment is right for lipoedema?

    Flat-knit compression garments are preferred for lipoedema, in contrast to circular-knit garments typically used for venous oedema. Flat-knit fabric is inelastic and provides firm, consistent compression without a tourniquet effect — important because lipoedematous limbs are often irregularly shaped. Class II compression (20–30 mmHg) is the minimum; class III (30–40 mmHg) is appropriate for more advanced disease or post-procedure. Garments should be worn on rising and removed at bedtime, replaced every six months as they lose elasticity. They are not PBS-funded; custom flat-knit costs approximately $150–$400 per garment.

  • What exercise is best for lipoedema?

    Water-based exercise — aquaaerobics, swimming, and hydrotherapy — is considered the gold standard because hydrostatic pressure provides natural compression while joint load is minimised. This is particularly relevant in later-stage disease where joint strain from disproportionate lower-limb weight affects the knees, hips, and ankles. Low-impact land-based exercise (cycling, walking, elliptical training) and strength training to preserve muscle mass are also appropriate. High-impact exercise that significantly loads the lower-limb joints should be avoided in Stage 3. An exercise physiologist via the GP Chronic Care Management Plan can provide an individualised program.

Source quality

Sources grouped by evidence tier. AU primary tier first; international where AU is silent or lagging; named-author reconstruction where guidelines have not yet caught up. How tiers work.